Exagen Inc.XGNNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank72
5Y CAGR+9.4%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+9.4%/yr
Long-term compound
Percentile
P72
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202532.26%
Q3 2025-47.62%
Q2 2025-5.00%
Q1 20250.00%
Q4 202428.57%
Q3 2024-75.00%
Q2 202415.79%
Q1 202438.71%
Q4 20230.00%
Q3 2023-10.71%
Q2 202336.36%
Q1 202346.99%
Q4 2022-76.60%
Q3 202245.35%
Q2 2022-43.33%
Q1 2022-42.86%
Q4 20210.00%
Q3 2021-10.53%
Q2 202120.83%
Q1 2021-77.78%
Q4 202020.59%
Q3 2020-25.93%
Q2 202038.64%
Q1 2020-62.96%
Q4 201987.02%
Q3 201995.29%
Q2 2019-2.94%
Q1 2019-105.31%
Q4 201825.01%
Q3 201860.64%
Q2 201816.20%
Q1 20180.00%
Q4 201527.89%
Q3 201563.83%
Q2 2015-179.99%
Q1 2015-31.73%
Q4 201452.39%
Q3 2014-19.39%
Q2 2014-11.76%
Q1 201444.75%